Print- and Web-based tools presenting the benefits and limitations of PSA testing served to help men resolve their own conflicts regarding screening, but did not change their plans to undergo such testing. Kathryn L. Taylor, PhD, and co-investigators reported online in JAMA Internal Medicine that among 1,879 men randomized to a print-based decision aid (628 patients), a Web-based interactive decision aid (625 patients), or usual care (626 patients), decisional conflict was significantly lower for the intervention groups than for the usual-care patients at one and 13 months.
Screening rates at 13 months, however, did not differ significantly among groups.
Enjoying our content?
Thanks for visiting Renal & Urology News. We hope you’re enjoying the latest clinical news, full-length features, case studies, and more.
You’ve viewed {{metering-count}} of {{metering-total}} articles this month. If you wish to read unlimited content, please log in or register below. Registration is free.
{{login-button}} {{register-button}}
Log in to continue reading this article.
Don’t miss out on today’s top content on Renal & Urology News. Register for free and gain unlimited access to:
- Clinical News, with personalized daily picks for you
- Case Studies
- Conference Coverage
- Full-Length Features
- Drug Monographs
- And More
{{login-button}} {{register-button}}
Want to read more?
Please login or register first to view this content.